Publications by authors named "Ian Dainty"

Claim this Profile
R
RORγt inverse agonists demonstrating a margin between inhibition of IL-17A and thymocyte apoptosis.
Mia Collins, Rikard Pehrson, Hanna Grindebacke, Agnes Leffler, Marie Ramnegård, Ian Dainty

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double-blind, efficacy, and safety study.
Jacob M van Laar, Alejhandra Lei, Mary Safy-Khan, Joachim Almquist, Graham Belfield, Ian Dainty

Clin Transl Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quaternary glucocorticoid receptor structure highlights allosteric interdomain communication.
Sandra Postel, Lisa Wissler, Carina A Johansson, Anders Gunnarsson, Euan Gordon, Ian Dainty

Nat Struct Mol Biol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β Adrenergic Receptor Agonist Navafenterol in Human Small Airways.
Joseph Antony Jude, Ian Dainty, Nikhil Karmacharya, William Jester, Reynold Panettieri

Cells· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide enhances agonist-induced bronchodilation in human small airways by increasing cAMP production in airway smooth muscle.
Cynthia Koziol-White, Timothy B Johnstone, Maia L Corpuz, Gaoyuan Cao, Sarah Orfanos, Ian Dainty

Am J Physiol Lung Cell Mol Physiol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking of Human Dose Prediction for Inhaled Medicines from Preclinical In Vivo Data.
Therese Ericsson, Markus Fridén, Carina Kärrman-Mårdh, Ian Dainty, Ken Grime

Pharm Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist.
David J Nicholls, Katherine Wiley, Ian Dainty, Fraser MacIntosh, Caroline Phillips

J Pharmacol Exp Ther· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists.
Lilian Alcaraz, Andrew Bailey, Elaine Cadogan, Stephen Connolly, Robert Jewell, Ian Dainty

Bioorg Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposure.
Caroline Düringer, Gunilla Grundström, Eylem Gürcan, Ian A Dainty, Mandy Lawson

Br J Pharmacol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ca(2+) signalling by recombinant human CXCR2 chemokine receptors is potentiated by P2Y nucleotide receptors in HEK cells.
Tim D Werry, Mark I Christie, Ian A Dainty, Graeme F Wilkinson, Gary B Willars

Br J Pharmacol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis